Position statement by Experts of the Polish Menopause and Andropause Society, and the Polish Society of Aesthetic and Reconstructive Gynaecology on the medicinal product Intrarosa
| Autor: | Maciej Wilczak, Małgorzata Bińkowska, Tomasz Paszkowski, Skrzypulec-Plinta Violetta, Wojciech Zgliczyński |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Position statement
medicine.medical_specialty 030219 obstetrics & reproductive medicine business.industry Genitourinary system Endocrinology Diabetes and Metabolism lcsh:R MEDLINE lcsh:Medicine Obstetrics and Gynecology Scientific literature medicine.disease Terminology Menopause 03 medical and health sciences 0302 clinical medicine Family medicine medicine Featured Paper Product (category theory) business Reproductive health |
| Zdroj: | Przegla̜d Menopauzalny = Menopause Review Menopause Review, Vol 18, Iss 3, Pp 127-132 (2019) |
| ISSN: | 1643-8876 |
| Popis: | A set of menopause-related symptoms affecting the external genitalia and lower urinary tract is discussed in contemporary scientific literature under the name of urogenital atrophy (UGA) or vulvovaginal atrophy (VVA) [1]. In 2014, a team of experts from two scientific associations – The North American Menopause Society (NAMS) and The International Society for the Study of Women’s Sexual Health (ISSWSH) – proposed a new terminology for postmenopausal atrophic symptoms, replacing the terms VVA and UGA with the term genitourinary syndrome of menopause (GSM) [2]. The change was motivated by the belief that this set of symptoms requires a more holistic therapeutic approach falling outside the scope of interest of gynaecologists and urologists only. The signs and symptoms of GSM are summarised in the Table 1. Table 1 Genitourinary syndrome of menopause (GSM) –symptoms and signs |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|